FAKTOR OPTIONSSCHEIN - MERCK & CO. | Market Closed - BOERSE MUENCHEN 11:55:06 17/05/2024 pm IST | ||
| 17.76 EUR | +0.11% |
|
| Current month | -4.73% | ||
| 1 month | -10.64% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 17.76 | +0.11% |
| 16/24/16 | 17.74 | +0.31% |
| 15/24/15 | 17.69 | -4.63% |
| 14/24/14 | 18.55 | +0.17% |
| 13/24/13 | 18.52 | +2.34% |
Real-time BOERSE MUENCHEN
Last update May 17, 2024 at 11:55 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GG2ZGA |
| ISIN | DE000GG2ZGA5 |
| Date issued | 31/01/2024 |
| Strike | 196.3 $ |
| Maturity | Unlimited |
| Parity | 3.39 : 1 |
| Emission price | 21.3 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.89 € |
|---|---|
| Lowest since issue | 17.53 € |
| Spread | 0.03 € |
| Spread % | 0.17% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.2
USD
Average target price
141.6
USD
Spread / Average Target
+7.96%
- Stock Market
- Certificates
- Certificat
